• SENSEX 80,567.71
    409.83 (+0.51%)
  • BANKNIFTY 54,067.55
    406.55 (+0.76%)
  • Ola Electric
    70.25 123.90(%)
  • N S D L
    1,236.20 880.00(%)
  • Aditya Vision
    447.00 328.25(%)
  • Vimta Labs
    829.00 787.20(%)
  • One Mobikwik
    300.00 698.30(%)
  • Tata Steel
    168.00 170.20(%)
  • Netweb Technol.
    2,564.75 3,060.00(%)
  • Apollo Micro Sys
    306.60 298.70(%)
  • Aurobindo Pharma
    1,041.00 1,592.55(%)
  • Jai Corp
    170.15 406.00(%)
  • Moschip Tech.
    196.45 279.00(%)
  • Godfrey Phillips
    10,420.00 11,462.00(%)
  • Yes Bank
    20.38 24.40(%)
  • M & M
    3,292.60 3,430.10(%)
  • NTPC
    333.45 292.70(%)
  • TBO Tek
    1,609.20 2,000.00(%)
  • AU Small Finance
    716.05 840.95(%)
  • Larsen & Toubro
    3,606.35 3,963.00(%)
  • TCS
    3,087.75 2,992.05(%)
  • Bharat Electron
    381.05 435.95(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Ind-Swift Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 7927.0
  • ISIN : INE915B01019
102.57 4 (3.55%)
  • As on 03 Sep 2025 (EOD)

  • Today’s Low

    98.15

  • Today’s High

    103.90

  • Open

    100.45

  • Perv Close

    99.05

  • 52W Low

    68.72

  • 52W High

    158.56

Key Indicators

  • P/E(TTM)

    33.53

  • Mar.Cap (₹Cr.)

    727.89

  • Div & Yield %

    0.00

  • Book Value(₹)

    178.49

  • Debt-Equity Ratio

    3.55

  • AGM Date

    03-Sep-2025

  • EPS

    2.97

  • P/E Ratio

    33.53

Financials Ratios

  • Debt-Equity Ratio

    0.61

  • Mar.Cap (₹Cr.)

    727.89

  • RONW (%)

    19.32

  • ROCE (%)

    20.71

Score Board

  • Equity (₹ in Cr.)

    73.49

  • BV (₹)

    178.50

  • Sales( ₹ in Cr.)

    549.65

  • NP (in Cr.)

    42.92

  • NP Var(%)

    -69.0

  • Div%

    0.0

  • CPS (₹)

    9.20

  • EPS (₹)

    5.80

  • Traded Value (₹ in Lakhs)

    731.86

  • 52 Week High

    158.56

  • 52 Week Low

    68.72

  • Price BSE

    100.0

  • Price NSE

    99.00

  • Market Capital( in Cr.)

    731.86

  • P/C Ratio

    10.90

  • P/E Ratio

    17.10

  • Price Vs.BV

    5.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 1,227.32 1,151.96 988.09 856.58 751.84 724.43
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,227.32 1,151.96 988.09 856.58 751.84 724.43
Other Income 431.90 33.28 42.50 23.13 36.02 129.94
Stock Adjustments -37.07 12.34 39.47 2.48 12.44 14.20
Total Income 1,622.15 1,197.58 1,070.06 882.19 800.30 868.57
EXPENDITURE :            
Raw Materials 586.51 629.18 537.62 427.47 391.29 397.43
Power and Fuel Cost 61.43 76.07 58.40 37.31 34.65 37.44
Employee Cost 148.88 132.70 124.62 104.17 100.38 88.94
Other Manufacturing Expenses 42.34 38.53 36.51 28.76 25.73 25.70
Selling and Administration Expenses 77.92 63.98 62.17 78.98 69.66 63.48
Miscellaneous Expenses 23.20 28.40 16.22 1.87 0.62 0.39
Employee Benefit Expenses 148.88 132.70 124.62 104.17 100.38 88.94
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 940.28 968.85 835.54 678.56 622.32 613.39
Operating Profit 681.87 228.73 234.52 203.63 177.98 255.18
Interest 51.10 92.17 95.55 100.22 107.48 92.20
Gross Profit 630.77 136.56 138.97 103.41 70.50 162.98
Depreciation 53.30 57.36 130.97 87.29 90.06 104.05
Profit Before Tax 577.47 79.20 8.00 16.12 -19.56 58.93
Current Tax 169.92 13.36 24.62 11.04 0.41 3.35
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -10.84 23.36 -10.92 9.48 0.82 16.99
Reported Net Profit 418.39 42.47 -5.71 -4.40 -20.79 38.58
Extraordinary Items 280.50 -13.39 -3.13 0.00 0.07 65.91
Adjusted Net Profit 137.89 55.86 -2.58 -4.40 -20.86 -27.33
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 -3.96
P & L Balance brought forward -37.69 -80.16 -74.45 -70.05 -49.26 -83.89
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 380.70 -37.69 -80.16 -74.45 -70.05 -49.26
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 70.81 7.10 -0.95 -0.74 -3.48 7.99
Earnings Per Share(Adj)-Unit Curr 70.81 7.10 -0.95 -0.74 -3.48 7.99
Book Value 156.08 82.26 72.91 71.55 70.15 72.58
Book Value(Adj)-Unit Curr 156.08 82.26 72.91 71.55 70.15 72.58

Shareholding Pattern

  • Promoter Group

    37.72%

  • Public Share Holding

    62.28%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 25,227,507 34.33 25,227,507 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,491,276 3.39 2,491,276 17
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 27,718,783 37.72 27,718,783 18
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 12,259,341 16.68 12,259,341 8
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 554,040 0.75 554,040 3
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 12,813,381 17.44 12,813,381 11
2] Non Institution
Bodies Corporate 4,069,371 5.54 4,059,571 168
Clearing Members 167,090 0.23 167,090 17
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,545,240 2.10 1,545,240 416
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,004,450 1.37 1,004,450 671
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 15,042,942 20.47 15,042,942 153
Individuals holding nominal share capital up to Rs. 1 lakh 10,529,384 14.33 10,399,034 27,417
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 390,435 0.53 390,435 3
Sub Total 32,954,696 44.84 32,814,546 28,863
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 73,486,860 100.00 73,346,710 28,892

Company Background

Ind-Swift Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Ind-Swift Laboratories Ltd
  • BSE Code : 7927.0
  • ISIN : INE915B01019

  • Incorporation Year

    1995

  • Registered Office

    SCO 850 Shivalik Enclave
    NAC Manimajra, Chandigarh,
    Chandigarh-160101

  • Telephone

    91-0172-5061850/2730920

  • FAX

    91-0172-2730504/2736294

  • Chairman

    N R Munjal

  • Managing Director

    N R Munjal

  • Company Secretary

    Pradeep Verma

  • Auditor

    Avishkar Singhal & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Alankit Assignments Ltd
    205/208,
    Anarkali Market,Jhandewalan Extn
    Mumbai - New Delhi - 110055

Ind-Swift Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Ind-Swift Labs. 99.59 1,272.63 1,227.32 3.24 20.55
Abbott India 32,356.30 6,684.73 6,409.15 47.34 44.95
Astrazeneca Phar 8,937.85 1,756.92 1,716.29 121.87 32.94
P & G Health Ltd 6,321.25 944.52 934.17 34.91 40.23
Glaxosmi. Pharma 2,749.15 3,866.05 3,723.49 49.44 58.72
Cipla 1,568.95 20,029.57 19,044.85 23.45 21.40
Amrutanjan Healt 729.20 469.50 451.82 38.66 21.89
Guj. Themis Bio. 376.95 152.47 150.80 92.16 27.21
Fermenta Biotec. 328.45 442.21 430.53 10.90 17.61
Bliss GVS Pharma 159.40 703.42 667.20 23.83 9.16
Ambalal Sarabhai 32.71 19.33 4.04 17.13 2.10